[go: up one dir, main page]

AU2001237412A1 - Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines - Google Patents

Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines

Info

Publication number
AU2001237412A1
AU2001237412A1 AU2001237412A AU3741201A AU2001237412A1 AU 2001237412 A1 AU2001237412 A1 AU 2001237412A1 AU 2001237412 A AU2001237412 A AU 2001237412A AU 3741201 A AU3741201 A AU 3741201A AU 2001237412 A1 AU2001237412 A1 AU 2001237412A1
Authority
AU
Australia
Prior art keywords
lines
intramembrane
presenilin
deficient
screening methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237412A
Inventor
Wim Annaert
Bart De Strooper
An Herreman
Luc Schoonjans
Lutgarde Serneels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB
Publication of AU2001237412A1 publication Critical patent/AU2001237412A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001237412A 2000-02-25 2001-02-21 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines Abandoned AU2001237412A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200671 2000-02-25
EP00200671 2000-02-25
PCT/EP2001/002127 WO2001062897A1 (en) 2000-02-25 2001-02-21 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines

Publications (1)

Publication Number Publication Date
AU2001237412A1 true AU2001237412A1 (en) 2001-09-03

Family

ID=8171102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237412A Abandoned AU2001237412A1 (en) 2000-02-25 2001-02-21 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines

Country Status (4)

Country Link
US (1) US20030059938A1 (en)
EP (1) EP1257633A1 (en)
AU (1) AU2001237412A1 (en)
WO (1) WO2001062897A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1495329B1 (en) * 2002-04-18 2006-03-29 Esbatech AG Method for the identification of modulators of a secretase activity
HRP20050461A2 (en) * 2002-11-26 2005-08-31 Pharmacia & Upjohn Company Llc Soluble notch-based substrates for gamma secretase and methods and compositions for using same
EP1670903B1 (en) * 2003-09-05 2007-08-29 Cellzome Ag Treatment of neurodegenerative diseases
DE602004010314T2 (en) * 2004-08-09 2009-03-05 Cellzome Ag TREATMENT OF NEURODEEGENERATIVE DISORDERS BY USING DEGS INHIBITORS
US20060266367A1 (en) * 2005-05-27 2006-11-30 Alisa Noce Nasal dilator
US8129334B2 (en) 2006-03-31 2012-03-06 The Regents Of The University Of California Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
JP2009532674A (en) 2006-03-31 2009-09-10 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and for improving normal memory

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103523A (en) * 1996-04-29 2000-08-15 Thromb-X N.V. Pluripotent rabbit cell lines and method of making
WO1998051781A1 (en) * 1997-05-14 1998-11-19 Merck & Co., Inc. Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background
DE19856261C1 (en) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
DE19920514A1 (en) * 1999-05-05 2000-11-16 Boehringer Ingelheim Pharma Methods for finding proteases that specifically cleave membrane-bound substrates

Also Published As

Publication number Publication date
WO2001062897A1 (en) 2001-08-30
US20030059938A1 (en) 2003-03-27
EP1257633A1 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
IL155500A0 (en) Stenoprophiluric matrices and methods for making and using the same
GB0121314D0 (en) β-Secretase enzyme compositions and methods
AU2001275441A1 (en) Filter arrangement and methods
EP1218446A4 (en) Adhesives and method for making same
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU6073499A (en) Method to prevent xenograft transplant rejection
AU2001253743A1 (en) Vertical filter and method
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2001296709A1 (en) Gemstone
AU2001251137A1 (en) Methods and products for regulating cell motility
AU2001253020A1 (en) Screening markers and methods for neurodegenerative disorders
AU2001264134A1 (en) Microconnectors and method for their production
EP1469316A2 (en) Screening method
AU2002231295A1 (en) Developed seed and methods for making the same
AUPQ777500A0 (en) Grinding apparatus
AU1359401A (en) Chemoreceptors in plant parasitic nematodes
AU1223000A (en) Methods for screening protease variants for use in detergent compositions
AU2001237412A1 (en) Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
AU2001235535A1 (en) Abrasive grindstone and method for making same
AU2001290855A1 (en) Method and cell composition for screening compounds for anti-inflammatory activity
AU5625700A (en) Detergent particles and processes for making them
AU3721799A (en) Examining diamonds
AU2002243285A1 (en) Auxiliary metering apparatus and methods
AU2001274291A1 (en) Filter assemblies